Neogen Corporation (NEOG)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Neogen Corporation (NEOG) is up 26.3% since the beginning of the year. At $9 per share, NEOG is trading 22.7% below its 52-week high of $11. Investors who bought $1,000 worth of NEOG shares 5 years ago would now be looking at an investment worth $193.

Neogen Corporation (NEOG) has returned 26.32% so far this year and 85.12% over the past 12 months. Over the last ten years, NEOG has returned -7.64% per year, falling short of the S&P 500 Index benchmark, which averaged 13.71% annually.

Based on dividend-adjusted daily data since Feb 10, 1994, NEOG's average daily return is +0.07%, while the average monthly return is +1.32%. At this rate, an investment would double in approximately 4.4 years.

Historically, 55% of months were positive and 45% were negative. The best month was Jan 2001 with a return of +58.5%, while the worst month was Apr 2025 at -41.8%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 8 months.

On a daily basis, NEOG closed higher 47% of trading days. The best single day was Jan 8, 2026 with a return of +31.6%, while the worst single day was Apr 9, 2025 at -28.7%.

Neogen Corporation has an annualized alpha of 11.24%, beta of 0.69, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since February 10, 1994.

• Beta of 0.69 may look defensive, but with R2 of 0.08 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

NEOG ranks 82 for risk / return — in the top 82% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Neogen Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Neogen Corporation was 90.92%, occurring on Apr 17, 2025. The portfolio has not yet recovered.

The current Neogen Corporation drawdown is 81.73%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Neogen Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Neogen Corporation is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.